![Atreca Inc](/common/images/company/N_BCEL.png)
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (βAtrecaβ) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
SAN CARLOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -0.1006 | -40.1436552275 | 0.2506 | 0.38 | 0.15 | 1306997 | 0.28488625 | CS |
52 | -0.85 | -85 | 1 | 1.0663 | 0.1023 | 4118373 | 0.28488059 | CS |
156 | -6.86 | -97.8601997147 | 7.01 | 8.41 | 0.1023 | 1367908 | 1.22074702 | CS |
260 | -14.77 | -98.9946380697 | 14.92 | 29.35 | 0.1023 | 894614 | 2.8252815 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.